Compound Detail

CHEMBL5421629

Enter ChEMBL ID:

Free Research Context This compound will appear in recent viewed items on the research home for this browser.

CCN(CC)CCn1cc(CNC2=C3C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC2=O)C3=O)nn1

ChEMBL ↗ Properties Compare Identifier

Basic Information

ChEMBL ID	CHEMBL5421629
Phase	Preclinical
Structure Type	MOL
InChI Key	WAGAOXZHAHLPDF-YPASYZBJSA-N

Targets

Activities

Assay Types

PK Parameters

Publications

Known Names

725.9

MW (Da)

2.49

ALogP

HBA

HBD

200.2

PSA (Å²)

0.19

QED

Ro5 Violations

Rot. Bonds

Availability	Unknown
Chirality	Unknown

First in Class Prodrug

IC50 4 meas. best 6.29

Target	Type	Best pChEMBL	Mean pChEMBL	Best (nM)	# Data
PC-3 CHEMBL390	IC50	6.29	6.29	510.0	1
SK-OV-3 CHEMBL614925	IC50	6.28	6.28	520.0	1
SK-BR-3 CHEMBL613834	IC50	6.23	6.23	590.0	1
NHDF CHEMBL614200	IC50	6.02	6.02	960.0	1

Top measurements by pChEMBL value

Target	Type	Rel.	Value	Units	pChEMBL	Assay	PubMed
PC-3	IC50	=	510.0	nM	6.29	Anticancer activity against human PC-3 cells assessed as cell growth inhibition ...	37210951
SK-OV-3	IC50	=	520.0	nM	6.28	Anticancer activity against human SK-OV-3 cells assessed as cell growth inhibiti...	37210951
SK-BR-3	IC50	=	590.0	nM	6.23	Anticancer activity against human SK-BR-3 cells assessed as cell growth inhibiti...	37210951
NHDF	IC50	=	960.0	nM	6.02	Cytotoxicity against human HDF cells assessed as cell growth inhibition incubate...	37210951

PubMed	DOI	Target Context	# Activities
37210951	10.1016/j.ejmech.2023.115450	ADMET	2
37210951	10.1016/j.ejmech.2023.115450	SK-BR-3	1
37210951	10.1016/j.ejmech.2023.115450	SK-OV-3	1
37210951	10.1016/j.ejmech.2023.115450	PC-3	1
37210951	10.1016/j.ejmech.2023.115450	NHDF	1
37210951	10.1016/j.ejmech.2023.115450	Unchecked	1

Data from ChEMBL 36 via Core Engine